Chen et al. [20] found regorafenib triggered p53-upregulated modulator of apoptosis (PUMA)-mediated apoptosis through induction of NF-κB pathway in colorectal cancer in vitro and in vivo. The gene discussed is TP53; the disease is colorectal cancer.